A new evergreen open-ended global fund investing in Health, Agricultural biotechnology and Industrial biotechnology companies.Unique Fund Structure• Evergreen, open-ended Fund enabling continuous and flexible deal flow• No sunset date or cap on the value of the fund• Geography-agnostic investments• Ongoing capital and strategic support for investments• Management remuneration aligned to investors' interests• Tax neutral location and tax-effective arrangements at all levels• Bespoke structure for significant investors with long-term horizon Maximise Investment Returns• Robust process for investment selection• Active ongoing involvement with investee companies to manage risk and maximise return• Income flows directly to investors • Flexible reinvestment pathways Investments That Make a Difference• The Fund invests in innovative and disruptive technologies in the biotech space – medical, agricultural, industrial• High growth diversified international later stage investments• Investments that matter to people because they make lives better or improve society as a whole• Measurable impact quantified by internationally accredited organisations• Built through alliances and collaborations with strategic partners, such as pharmaceutical companies, medical research institutes and universities and clinical research and manufacturing organisationsFirst Class Management Team• Experienced team with global networks and track record in commercialisation, licencing, fund development and investment management across Asia, Europe and North America• Managed from Australia, with satellite offices located in strategic geographies